Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting

Bah Malick; Toure Alhassane Ismael; Keita Mamady; Cisse Kalil; Souare Mamadou Bobo; Conde Ibrahima Kalil; Cisse Mohamed Falilou; Traore Bangaly

doi:doi:10.11648/j.crj.20231103.14

Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting

Bah Malick, Toure Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, Conde Ibrahima Kalil, Cisse Mohamed Falilou, Traore Bangaly

Published in Cancer Research Journal (Volume 11, Issue 3)

Received: 16 August 2023 Accepted: 1 September 2023 Published: 14 September 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.

Published in	Cancer Research Journal (Volume 11, Issue 3)
DOI	10.11648/j.crj.20231103.14
Page(s)	105-111
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Ovarian Cancer, Treatment, Breast Cancer, Guinean Oncological Environment

References

[1]	Institut Curie. Breast cancer. [Accessed March 11, 2021]. Available at: https://curie.fr/page/le-cancer-du-sein
[2]	Lokossou A. Ovarian cancer: epidemiology, natural history, clinical study. Cours université d'Abomey- Calavi Bénin: 82p. [Accessed 04 February 2021]. Available from http://umvf.cerimes.fr/media/ressMereEnfant/CAN/Libreville2012/videocours/3-02-Libreville2012-Lokossou_html5/media/pdf/3.02_Lokossou.pdf
[3]	Schonfeld SJ, Berrington de Gonzalez A, Visvanathan K, et al. Declining second primary ovarian cancer after first primary breast cancer. J Clin Oncol. 2013; 31 (6): 738-43.a.
[4]	Zoukar O, Haddad A, Daldoul A et al. Genital metastases from breast cancer: study of 3 cases and literature review. Pan Afr Med J. 2018; 30 (7): 7.
[5]	Curtis RE, Freedman DM, Ron E, et al. New malignancies among cancer survivors. [Accessed 06 February 2021]. Available at: https://seer.cancer.gov/archive/publications/mpmono/
[6]	Crouet H, Lesur A, Blanc-Fournier C et al. Ovarian, peritoneal and retroperitoneal metastases in breast cancer. 29th meeting of the French Society of Senology and Breast Pathology (SFSPM). Advanced breast cancer. Avignon, France. 2007. 239p.
[7]	Wang J., Tian W., Zhou Y. et al. Ovarian metastasis from breast cancer in three Chinese females: Three case reports. China: Wolters Kluwer Health, Inc; 2019; 98 (17); e15395.
[8]	Dubois N., Willems T., Myant N. Métastase ovarienne du cancer du sein: à propos d'un cas. Rôle de la chirurgie cytoréductrice. Eur J Obst Gyn Reprod Biol; 2009; 38 (3): 242-245.
[9]	Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J Clin. 2009 59 (4): 225-49.
[10]	Kondi-Pafiti A, Kairi-Vasilatou E, Iavazzo C et al. Metastatic neoplasms of the ovaries: a clinicopathological study of 97 cases. Arch Gynecol Obstet. 2011; 284 (5): 1283-8.
[11]	Chabbert-Buffet N, Seroussi B, Chopier J et al. Modalités de fonctionnement d'un centre de prise en charge des femmes à haut risque de cancer du sein et de l'ovaire: l'expérience française de l'hôpital Tenon. Gynecol Obstet Fertil. 2010; 38 (3): 183-92.
[12]	Antila R, Jalkanen J, Heikinheimo O. Comparison of secondary and primary ovarian malignancies reveals differences in their pre-and perioperative characteristics. Gynecol Oncol. 2006; 101 (1): 97-101.
[13]	Le Thai N, Lasry S, Brunet M et al. Cancer de l'ovaire après cancer du sein. 45 cars. J Gynecol Obstet Biol Reprod (Paris). 1991; 20 (8): 1043-8.
[14]	Gagnon Y, Têtu B. Métastases ovariennes d'un carcinome mammaire. Etude clinicopathologique de 59 cas. Cancer. 1989; 64 (4): 892-8.
[15]	Le Bouëdec G, de Latour M, Levrel O, Dauplat J. Tumeurs de krükenberg d'origine mammaire. 10 observations. Presse Med. 1997 Mar 29; 26 (10): 454-7.
[16]	Perrotin F, Marret H, Bouquin R et al. Incidence, diagnostic et pronostic des métastases ovariennes dans le cancer du sein. Gynecol Obstet Fertil. 2001; 29 (4): 308-15.
[17]	Société canadienne du cancer. Facteurs de risque du cancer du sein. [Consulté le 03 mai 2021]. Disponible sur: https://www.cancer.ca:443/fr-ca/cancer-information/cancertype/breast/risks/?region=qc.
[18]	Rabban JT, Barnes M, Chen L-M et al. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009; 33 (8): 1125-36.
[19]	Ayhan A, Guvenal T, Salman MC et al. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol. 2005; 98 (2): 235-41.
[20]	Abu-Rustum NR, Aghajanian CA, Venkatraman ES et al. Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol. 1997; 66 (1): 41-4.
[21]	Han X, Jemal A. Recent Patterns in Genetic Testing for Breast and Ovarian Cancer Risk in the U. S. Am J Prev Med. 2017; 53 (4): 504-7.
[22]	Schneider J, Lahl J, Kramer W. Risque de cancer du sein à long terme après stimulation ovarienne chez les jeunes donneuses d'ovules: un appel au suivi, à la recherche et au consentement éclairé. Reprod Biomed Online. 2017; 34 (5): 480-5.

Cite This Article

Plain Text BibTeX RIS

APA Style

Bah Malick, Toure Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, et al. (2023). Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Research Journal, 11(3), 105-111. https://doi.org/10.11648/j.crj.20231103.14

Copy | Download

ACS Style

Bah Malick; Toure Alhassane Ismael; Keita Mamady; Cisse Kalil; Souare Mamadou Bobo, et al. Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Res. J. 2023, 11(3), 105-111. doi: 10.11648/j.crj.20231103.14

Copy | Download

AMA Style

Bah Malick, Toure Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, et al. Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Res J. 2023;11(3):105-111. doi: 10.11648/j.crj.20231103.14

Copy | Download

@article{10.11648/j.crj.20231103.14,
  author = {Bah Malick and Toure Alhassane Ismael and Keita Mamady and Cisse Kalil and Souare Mamadou Bobo and Conde Ibrahima Kalil and Cisse Mohamed Falilou and Traore Bangaly},
  title = {Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting},
  journal = {Cancer Research Journal},
  volume = {11},
  number = {3},
  pages = {105-111},
  doi = {10.11648/j.crj.20231103.14},
  url = {https://doi.org/10.11648/j.crj.20231103.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20231103.14},
  abstract = {Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting
AU  - Bah Malick
AU  - Toure Alhassane Ismael
AU  - Keita Mamady
AU  - Cisse Kalil
AU  - Souare Mamadou Bobo
AU  - Conde Ibrahima Kalil
AU  - Cisse Mohamed Falilou
AU  - Traore Bangaly
Y1  - 2023/09/14
PY  - 2023
N1  - https://doi.org/10.11648/j.crj.20231103.14
DO  - 10.11648/j.crj.20231103.14
T2  - Cancer Research Journal
JF  - Cancer Research Journal
JO  - Cancer Research Journal
SP  - 105
EP  - 111
PB  - Science Publishing Group
SN  - 2330-8214
UR  - https://doi.org/10.11648/j.crj.20231103.14
AB  - Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.
VL  - 11
IS  - 3
ER  -

Copy | Download

Author Information

Bah Malick

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Toure Alhassane Ismael

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Keita Mamady

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Cisse Kalil

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Souare Mamadou Bobo

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Conde Ibrahima Kalil

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Cisse Mohamed Falilou

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea
Traore Bangaly

Surgical Oncology Unit at Donka National Hospital, Conakry University Hospital, Conakry, Guinea

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Bah Malick, Toure Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, et al. (2023). Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Research Journal, 11(3), 105-111. https://doi.org/10.11648/j.crj.20231103.14

Copy | Download

ACS Style

Bah Malick; Toure Alhassane Ismael; Keita Mamady; Cisse Kalil; Souare Mamadou Bobo, et al. Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Res. J. 2023, 11(3), 105-111. doi: 10.11648/j.crj.20231103.14

Copy | Download

AMA Style

Bah Malick, Toure Alhassane Ismael, Keita Mamady, Cisse Kalil, Souare Mamadou Bobo, et al. Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting. Cancer Res J. 2023;11(3):105-111. doi: 10.11648/j.crj.20231103.14

Copy | Download

@article{10.11648/j.crj.20231103.14,
  author = {Bah Malick and Toure Alhassane Ismael and Keita Mamady and Cisse Kalil and Souare Mamadou Bobo and Conde Ibrahima Kalil and Cisse Mohamed Falilou and Traore Bangaly},
  title = {Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting},
  journal = {Cancer Research Journal},
  volume = {11},
  number = {3},
  pages = {105-111},
  doi = {10.11648/j.crj.20231103.14},
  url = {https://doi.org/10.11648/j.crj.20231103.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.crj.20231103.14},
  abstract = {Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Ovarian Cancer After Breast Cancer Treatment: Study of 03 Cases in a Guinean Oncological Setting
AU  - Bah Malick
AU  - Toure Alhassane Ismael
AU  - Keita Mamady
AU  - Cisse Kalil
AU  - Souare Mamadou Bobo
AU  - Conde Ibrahima Kalil
AU  - Cisse Mohamed Falilou
AU  - Traore Bangaly
Y1  - 2023/09/14
PY  - 2023
N1  - https://doi.org/10.11648/j.crj.20231103.14
DO  - 10.11648/j.crj.20231103.14
T2  - Cancer Research Journal
JF  - Cancer Research Journal
JO  - Cancer Research Journal
SP  - 105
EP  - 111
PB  - Science Publishing Group
SN  - 2330-8214
UR  - https://doi.org/10.11648/j.crj.20231103.14
AB  - Introduction: Ovarian cancer, the 1st cause of death from gynecological cancer, is any malignant proliferative process developed in the ovary, which may occur after a treated breast cancer. Objectives: To discuss the management and prognosis of ovarian cancer after breast cancer treatment through a series of 3 clinical cases in a Guinean oncology setting. Case 1: A 60-year-old patient presented with an ulcerating tumor of the uterine cervix, after treatment of a CCI, she benefited from 12 courses of palliative chemotherapy and died 04 months after her last course with decompensated anemia. Case 2: the 75-year-old female patient who presented with abdominal distension with ascites associated with a pelvic mass after treatment of a CCI, died of multivisceral failure. Case 3: A 61-year-old hypertensive diabetic patient presented with abdominal distension and a pelvic-abdominal mass. After treatment of a CCI, she underwent an exploratory laparotomy and died at D15 post-op in hypovolaemic shock. Conclusion: This study shows the need to include monitoring of gynecological organs in patients treated for breast cancer. The diagnosis was late and the prognosis was poor.
VL  - 11
IS  - 3
ER  -

Copy | Download